Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association Between Medication Possession Ratio, Virologic Failure and Drug Resistance in HIV-1–Infected Adults on Antiretroviral Therapy in Côte d'Ivoire

30 Dec 2010

Abstract excerpt

BACKGROUND: Adherence is a strong determinant of viral suppression with antiretroviral therapy (ART) but measuring it is challenging. Medication delivery can be measured accurately in settings with computerized prescription databases. We studied the association between medication possession ratio (MPR), virologic suppression, and resistance to ART in Côte d'Ivoire. METHODS: We conducted a prospective cohort study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV/AIDS drug development and treatment
Share to HIV/AIDS Research and Interventions
Share to HIV-related health complications and treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21191309
DOI: 10.1097/qai.0b013e3182084b5a

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association Between Medication Possession Ratio, Virologic Failure and Drug Resistance in HIV-1–Infected Adults on Antiretroviral Therapy in Côte d'IvoirePMID 21191309Read ↗

Increasing rate of TAMs and etravirine resistance in HIV-1-infected adults between 12 and 24 months of treatment: the VOLTART cohort study in Côte d'Ivoire, West Africa.Semantic proximity Read ↗

Adherence and preexisting major protease inhibitor resistance mutations are associated with virologic failure of a dual-class antiretroviral regimen with inhibitors of HIV-1 viral protease and integrase.Semantic proximity Read ↗

Combination Anti-Retroviral Therapy (cART) Prescription Patterns and Their Efficacy in Suppressing HIV Viral Load among HIV-1 Positive Patients in Tigray Region, Northern Ethiopia.Semantic proximity Read ↗

Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda.Semantic proximity Read ↗

High levels of adherence do not prevent accumulation of HIV drug resistance mutations.Semantic proximity Read ↗

Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors.Semantic proximity Read ↗

Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy.Semantic proximity Read ↗

Modeling the HIV Protease Inhibitor Adherence–Resistance Curve by Use of Empirically Derived EstimatesSemantic proximity Read ↗

Accumulation of HIV-1 Drug Resistance Mutations and Methamphetamine Use.Semantic proximity Read ↗

Changes in the use of HIV antiretroviral resistance testing in a large cohort of U.S. patients, 1999 to 2006.Semantic proximity Read ↗

Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.Semantic proximity Read ↗

Might ART Adherence Estimates Be Improved by Combining Biomarker and Self-Report Data?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.